CD27L-ANTIGEN-BINDENDE PROTEINE
European patent · EP2758437 · In force
Register entry
- Publication number
- EP2758437
- Application number
- EP12766835
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 20, 2012
- Published
- Jul 30, 2014
- Granted
- Jun 3, 2020
- Protection ends at the latest
- Sep 19, 2032
- Next annual fee due
- Sep 30, 2027
- IPC classes
- C07K 16/28 (2006.01)A61K 39/395 (2006.01)A61P 35/00 (2006.01)A61P 37/00 (2006.01)
- Priority
- US 201161538024 P 22.09.2011
- PCT application
- PCT/US2012/056429 20.09.2012
- PCT publication
- WO2013/043933 28.03.2013
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- Oct 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.09.2025 → 30.09.2026
Published in Swissreg on 01.10.2025
- Oct 3, 2024
Change
Published in Swissreg on 03.10.2024
- Oct 1, 2023
Change
Published in Swissreg on 01.10.2023
- Oct 1, 2022
Change
Published in Swissreg on 01.10.2022
- Jun 3, 2020
Granted
Published in Swissreg on 03.06.2020
Parties
Inventor
DELANEY, John M.
Bellevue, WA 98004, US
KING, Chadwick Terence
North Vancouver, British Columbia V7L 3T5, CA
FANSLOW, William Christian, III
Normandy Park, WA 98166, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.